Exelixis

Prezzo Delle Azioni
45.14
Cambio Giornaliero
1.13 2.57%
Mensile
3.51%
Annuale
22.26%
Q1 Previsione
42.28




Ebit Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR -399M 363M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Cytokinetics USD -166.76M 55.25M 2025-09
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD -16.03M 11.51M 2024-09
Exelixis USD 235.91M 20.45M 2025-12
Genmab DKK 432M 900.27M 2025-06
Glaxosmithkline GBP 3.76B 1.69B 2025-09
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
MacroGenics USD 20.16M 55.51M 2025-09
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD -9.19B 13.87B 2025-06
Pfizer USD 4.65B 71M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sanofi EUR 3.74B 2.23B 2025-09
Takeda JPY 257.49B 568.56B 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Xencor USD -47.52M 24.69M 2025-09


Exelixis - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.